SBIR/STTR Research Award

Development and Pre-Clinical Testing of a Smart Defibrillator Algorithm for Treatment of Cardiac Arrhythmias

Award identifier 7a04048518b0bc57755877aec97ff62f7e6367441229bcfc79d7505f20641b84Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$251,746

Program and phase

SBIR · Phase I

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Arrhythmia Dynamics LLC
Proposal award date
2021-07-15
Contract end date
2022-03-31
UEI
KP2FY5MTN1A5
Solicitation number
PA20-260
Topic code
NHLBI

Research abstract

Project Summary / Abstract: Significance: Each year 300,000 to 400,000 patients experience sudden cardiac death in the United States. For patients at risk, implantable cardiac defibrillators (ICDs) improve survival, largely through the delivery of high energy shocks to restore sinus rhythm. While high energy shocks are clearly life-saving, they are not necessarily benign. Patients receiving high energy shocks have increased mortality and programming the device to reduce the number of shocks delivered can improve mortality. High energy shocks are associated with myocardial stunning, injury, and cell death. In addition, they are painful to the patient, are associated with significant healthcare costs, and result in more rapid battery depletion. Innovation: Arrhythmia Dynamics, LLC is developing the IntelliSync ICD control algorithm which enable ICDs to save lives while minimizing the use of harmful and damaging high energy shocks. IntelliSync will do this in two ways: 1) recognizing ventricular arrhythmia episodes which have high probability of terminating on their own without therapy; and 2) making the delivery of low energy defibrillation more likely to terminate the arrhythmia by optimally timing it to a period of high baseline synchronization in the ventricular chambers. Approach: In this grant we propose testing the feasibility of these algorithms in computational and rat models of ventricular fibrillation. In order to be clinically relevant, the algorithms must function and guide the defibrillator’s decision quickly. The goal of our IntelliSync algorithm are 2-fold: 1) Analyze the first 6-8 seconds of an arrythmia within 2 seconds, recognize patterns of regional coupling within the heart that herald imminent arrhythmia termination. If identified, the algorithm would trigger the ICD to wait for VF to terminate on its own, and only deliver therapy after a time-out period has occurred. 2) Measure patterns of coupling within the heart and time low energy therapy (if appropriate) to a period of high synchronization when it is more likely to succeed. IntelliSync may also work for atrial fibrillation (AF) and could make an atrial defibrillator palatable if shocks above the pain threshold could be avoided. Aim 1 (months 1-6): Optimize algorithm performance in computational models of ventricular fibrillation Sub-aim 1A: Determine minimum spatiotemporal resolution needed to represent high density intracellular voltage maps. Sub aim 1B: Identify threshold of change in the RQA variable Entropy which predicts imminent termination. Sub-aim 1C: Demonstrate that low energy therapies can be effectively timed to periods of greater tissue synchronization. Aim 2 (months 3-9): Demonstrate feasibility of delivering low energy therapy timed to period of high synchronization based on real-time calculations in a small animal model of VF Sub aim 2A: Demonstrate that synchrony measured from limited epicardial sensors are representative of full optical maps Sub-aim 2B: Establish threshold values for the RQA variable Entropy which identify episodes likely to self-terminate Sub-aim 2C: Prospectively test threshold value of Entropy from Aim 2B. Sub-Aim 2D: Demonstrate feasibility of performing real-time RQA calculations to guide delivery of low energy therapy.Project Narrative: Arrhythmia Dynamics, LLC is developing the IntelliSync ICD control algorithm which enable ICDs to save lives will minimizing the use of harmful and damaging high energy shocks. Each year 300,000 to 400,000 patients experience sudden cardiac death in the United States. For patients at risk, implantable cardiac defibrillators (ICDs) improve survival, largely through the delivery of high energy shocks to restore sinus rhythm. While high energy shocks are clearly life- saving, they are not benign. High energy shocks are associated with myocardial stunning, injury, and cell death and patients receiving them have increased mortality. The IntelliSync ICD control algorithm which enable ICDs to save lives will minimizing the use of harmful and damaging high energy shocks by 1) recognizing ventricular arrhythmia episodes which have high probability of terminating on their own without therapy; and 2) timing low energy defibrillation to periods of synchronization where it is more likely to be effective.

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.